trial · primary record
BG-C477
Advanced Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 310 |
| Primary completion | 2028-07-23 |
| Primary endpoint | Phase 1a: Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT06596473 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:55.897Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06596473
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.